Category: Science Blog December 17, 2014
In the second part of this two-part series, we look at our work with industry, why it’s important, and how we try to influence the way drugs get to patients.
Category: Science Blog December 16, 2014
In this first in a two-part series, we take a look at how cancer drugs get to patients, and at some of reasons behind the spiralling costs.
Category: Science Blog December 2, 2014
We take a look at the latest data from a clinical trial testing a ‘sponge on a string’ as a new way to detect oesophageal cancer early.
Category: Science Blog October 24, 2014
Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK?
Category: Science Blog September 29, 2014
Something extraordinary is happening right now. Impelled by the Ebola outbreak in West Africa, researchers, medics, funding agencies, pharmaceutical companies a...